Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
JHEP Reports : Innovation in Hepatology|September 23, 2024
Stereotactic body radiotherapy is an alternative to radiofrequency ablation for single HCC ≤5.0 cmZhoutian Yang, Shiliang Liu, Li Hu, et al.
Journal of Clinical Medicine|January 8, 2023
A Nomogram Based on Preoperative Lab Tests, BMI, ICG-R15, and EHBF for the Prediction of Post-Hepatectomy Liver Failure in Patients with Hepatocellular CarcinomaDeyao Zhang, Yangxun Pan, Zhenyun Yang, et al.
Cancers|October 13, 2018
Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency AblationJinbin Chen, Kangqiang Peng, Dandan Hu, et al.
Journal of Hepatocellular Carcinoma|August 11, 2025
Social Support, Quality of Life, and Financial Toxicity Among Patients with Hepatocellular CarcinomaShuyue Liu, Yawen Xie, Tiantian Li, et al.
Carcinogenesis|January 3, 2018
A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in ChineseLei Yang, Di Wu, Jinbin Chen, et al.
Molecular Carcinogenesis|October 26, 2017
Long non-coding RNA AGER-1 functionally upregulates the innate immunity gene AGER and approximates its anti-tumor effect in lung cancerZihua Pan, Li Liu, Wenjing Nie, et al.
Radiology|February 4, 2025
Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular CarcinomaYao-Jun Zhang, Jinbin Chen, Zhongguo Zhou, et al.
Human Mutation|May 7, 2026
<i>GLUT1</i> rs1385129G>A Raised the Risk and Poor Prognosis of Lung Cancer: A Case-Control StudyZhi Li, Dedong Wang, Jinbin Chen, et al.
Frontiers in Pharmacology|September 21, 2023
Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinomaZhenyun Yang, Yizhen Fu, Weijie Wu, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2026
Stereotactic body radiotherapy versus hepatic resection for recurrent small hepatocellular carcinoma: A post-hoc analysis with propensity score adjustment from two randomized trialsYizhen Fu, Shiliang Liu, Jinbin Chen, et al.
Pageof 9